BioDelivery Sciences International Inc. announced the FDA approval of BELBUCA, a buccal film intended for the management of moderate to severe chronic...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves WG Critical Care's Dexmedetomidine Injection for Intravenous Use WG Critical Care, LLC has received FDA approval for its intravenous d...
# FDA Approves Apotex's Generic Ibandronate Sodium Injection Apotex Corp. received FDA approval for its generic ibandronate sodium intravenous formul...
PAI Holdings, LLC dba PAI Pharma has received FDA approval for its Abbreviated New Drug Application (ANDA 204431) for Buprenorphine Hydrochloride and ...
Epic Pharma, LLC received final FDA approval on September 22, 2015, for its ANDA for oxycodone hydrochloride oral solution, adding a critical generic ...
# FDA Approves Aurolife Pharma's Generic Methadone Hydrochloride Aurolife Pharma, LLC has received FDA approval for its generic methadone hydrochlori...
Boehringer Ingelheim Pharmaceuticals, Inc. announced the FDA approval of SYNJARDY (empagliflozin and metformin hydrochloride tablets), combining two w...
The FDA has granted final approval to Novel Laboratories, Inc. for its Abbreviated New Drug Application (ANDA) involving oxycodone hydrochloride, posi...
Alembic Pharmaceuticals Inc. has received U.S. FDA approval for the generic version of the prescription osteoarthritis medication Celecoxib (API Name)...
On August 18, 2015, Epic Pharma, LLC received approval for ANDA090065 to manufacture generic methadone hydrochloride tablets, a move expected to inten...
BAXTER HLTHCARE CORP received FDA approval on August 7, 2015, signaling a regulatory milestone that is poised to bolster the company's market position...
Amneal Pharmaceuticals of New York LLC announced late Friday that the FDA has granted tentative approval for its generic version of the ADHD medicatio...
FDA has accepted PERRIGO R AND D’s ANDA #204152, signaling the initiation of a pathway for a critical dosage form and highlighting the company's strat...
# FDA Approves Vertex Pharmaceuticals' ORKAMBI for Cystic Fibrosis Vertex Pharmaceuticals Incorporated received FDA approval for ORKAMBI (lumacaftor ...
Mainpointe Pharmaceuticals announced Tuesday that the FDA has approved TUXARIN (codeine phosphate and chlorpheniramine maleate), introducing a new bra...
Eugia US LLC received FDA approval for the intravenous generic version of azithromycin (ANDA 203294). This addition is expected to enhance generic mar...
Hospira, Inc. announced the FDA approval of its Linezolid Intravenous formulation, expanding the company's critically important portfolio of antibioti...
Pfizer Inc. has received approval for key filings related to its ANDA206456, filling a pivotal gap in the U.S. generic market for EchoPharm's branded ...
# FDA Approves Saptalis Pharmaceuticals' Generic Desoximetasone Topical Treatment Saptalis Pharmaceuticals, LLC has received FDA approval for its gen...
Advagen Pharma Ltd has received FDA approval for its Abbreviated New Drug Application (ANDA090279) to market buprenorphine hydrochloride tablets for s...